Human Hepatitis B Immunoglobulin Market

List of Tables
Table 1. Human Hepatitis B Immunoglobulin CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Human Hepatitis B Immunoglobulin Market Trends
Table 3. Human Hepatitis B Immunoglobulin Market Drivers
Table 4. Human Hepatitis B Immunoglobulin Market Challenges
Table 5. Human Hepatitis B Immunoglobulin Market Restraints
Table 6. Global Human Hepatitis B Immunoglobulin Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Human Hepatitis B Immunoglobulin Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Human Hepatitis B Immunoglobulin Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Human Hepatitis B Immunoglobulin Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Human Hepatitis B Immunoglobulin Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Human Hepatitis B Immunoglobulin Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Human Hepatitis B Immunoglobulin Revenue Share by Manufacturer, 2017-2022
Table 13. Global Human Hepatitis B Immunoglobulin Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Human Hepatitis B Immunoglobulin Sales Share by Manufacturer, 2017-2022
Table 15. Global Human Hepatitis B Immunoglobulin Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Human Hepatitis B Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Human Hepatitis B Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Hepatitis B Immunoglobulin as of 2021)
Table 18. Top Players of Human Hepatitis B Immunoglobulin in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Human Hepatitis B Immunoglobulin Product Type
Table 20. Date of International Manufacturers Enter into Human Hepatitis B Immunoglobulin Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Human Hepatitis B Immunoglobulin Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Human Hepatitis B Immunoglobulin Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Human Hepatitis B Immunoglobulin Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Human Hepatitis B Immunoglobulin Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Human Hepatitis B Immunoglobulin Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Human Hepatitis B Immunoglobulin Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Human Hepatitis B Immunoglobulin Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Human Hepatitis B Immunoglobulin Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Human Hepatitis B Immunoglobulin Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Human Hepatitis B Immunoglobulin Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Human Hepatitis B Immunoglobulin Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Human Hepatitis B Immunoglobulin Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Human Hepatitis B Immunoglobulin Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Human Hepatitis B Immunoglobulin Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Human Hepatitis B Immunoglobulin Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Human Hepatitis B Immunoglobulin Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Human Hepatitis B Immunoglobulin Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Human Hepatitis B Immunoglobulin Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Human Hepatitis B Immunoglobulin Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Human Hepatitis B Immunoglobulin Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Baxter Corporation Information
Table 43. Baxter Description and Business Overview
Table 44. Baxter Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. Baxter Human Hepatitis B Immunoglobulin Product
Table 46. Baxter Recent Development
Table 47. CSL Corporation Information
Table 48. CSL Description and Business Overview
Table 49. CSL Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. CSL Product
Table 51. CSL Recent Development
Table 52. Bayer Corporation Information
Table 53. Bayer Description and Business Overview
Table 54. Bayer Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Bayer Product
Table 56. Bayer Recent Development
Table 57. Grifols Corporation Information
Table 58. Grifols Description and Business Overview
Table 59. Grifols Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Grifols Product
Table 61. Grifols Recent Development
Table 62. Octapharma Corporation Information
Table 63. Octapharma Description and Business Overview
Table 64. Octapharma Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Octapharma Product
Table 66. Octapharma Recent Development
Table 67. Shanghai RAAS Corporation Information
Table 68. Shanghai RAAS Description and Business Overview
Table 69. Shanghai RAAS Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. Shanghai RAAS Product
Table 71. Shanghai RAAS Recent Development
Table 72. Hualan Biological Corporation Information
Table 73. Hualan Biological Description and Business Overview
Table 74. Hualan Biological Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 75. Hualan Biological Product
Table 76. Hualan Biological Recent Development
Table 77. China Biologic Corporation Information
Table 78. China Biologic Description and Business Overview
Table 79. China Biologic Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 80. China Biologic Product
Table 81. China Biologic Recent Development
Table 82. Tiantan Biologic Corporation Information
Table 83. Tiantan Biologic Description and Business Overview
Table 84. Tiantan Biologic Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 85. Tiantan Biologic Product
Table 86. Tiantan Biologic Recent Development
Table 87. Shuanglin Bio-pharmacy Corporation Information
Table 88. Shuanglin Bio-pharmacy Description and Business Overview
Table 89. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 90. Shuanglin Bio-pharmacy Product
Table 91. Shuanglin Bio-pharmacy Recent Development
Table 92. Sichuan Yuanda Shuyang Corporation Information
Table 93. Sichuan Yuanda Shuyang Description and Business Overview
Table 94. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 95. Sichuan Yuanda Shuyang Product
Table 96. Sichuan Yuanda Shuyang Recent Development
Table 97. Boya Bio-pharmaceutical Corporation Information
Table 98. Boya Bio-pharmaceutical Description and Business Overview
Table 99. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 100. Boya Bio-pharmaceutical Product
Table 101. Boya Bio-pharmaceutical Recent Development
Table 102. Shanghai Institute of Biological Corporation Information
Table 103. Shanghai Institute of Biological Description and Business Overview
Table 104. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 105. Shanghai Institute of Biological Product
Table 106. Shanghai Institute of Biological Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Human Hepatitis B Immunoglobulin Customers List
Table 110. Human Hepatitis B Immunoglobulin Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Hepatitis B Immunoglobulin Product Picture
Figure 2. Global Human Hepatitis B Immunoglobulin Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Human Hepatitis B Immunoglobulin Market Size 2017-2028 (US$ Million)
Figure 4. Global Human Hepatitis B Immunoglobulin Sales 2017-2028 (K MT)
Figure 5. United States Human Hepatitis B Immunoglobulin Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Human Hepatitis B Immunoglobulin Market Size 2017-2028 (US$ Million)
Figure 7. United States Human Hepatitis B Immunoglobulin Sales 2017-2028 (K MT)
Figure 8. United States Human Hepatitis B Immunoglobulin Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Human Hepatitis B Immunoglobulin Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Human Hepatitis B Immunoglobulin Report Years Considered
Figure 11. Product Picture of 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Figure 12. Product Picture of 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Figure 13. Product Picture of 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Figure 14. Global Human Hepatitis B Immunoglobulin Market Share by Type in 2022 & 2028
Figure 15. Global Human Hepatitis B Immunoglobulin Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Human Hepatitis B Immunoglobulin Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Human Hepatitis B Immunoglobulin Sales by Type (2017-2028) & (K MT)
Figure 18. Global Human Hepatitis B Immunoglobulin Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Human Hepatitis B Immunoglobulin Price by Type (2017-2028) & (USD/MT)
Figure 20. United States Human Hepatitis B Immunoglobulin Market Share by Type in 2022 & 2028
Figure 21. United States Human Hepatitis B Immunoglobulin Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Human Hepatitis B Immunoglobulin Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Human Hepatitis B Immunoglobulin Sales by Type (2017-2028) & (K MT)
Figure 24. United States Human Hepatitis B Immunoglobulin Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Human Hepatitis B Immunoglobulin Price by Type (2017-2028) & (USD/MT)
Figure 26. Product Picture of Hepatitis B Carrier
Figure 27. Product Picture of Hepatitis B Close Contacts
Figure 28. Global Human Hepatitis B Immunoglobulin Market Share by Application in 2022 & 2028
Figure 29. Global Human Hepatitis B Immunoglobulin Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Human Hepatitis B Immunoglobulin Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Human Hepatitis B Immunoglobulin Sales by Application (2017-2028) & (K MT)
Figure 32. Global Human Hepatitis B Immunoglobulin Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Human Hepatitis B Immunoglobulin Price by Application (2017-2028) & (USD/MT)
Figure 34. United States Human Hepatitis B Immunoglobulin Market Share by Application in 2022 & 2028
Figure 35. United States Human Hepatitis B Immunoglobulin Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Human Hepatitis B Immunoglobulin Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Human Hepatitis B Immunoglobulin Sales by Application (2017-2028) & (K MT)
Figure 38. United States Human Hepatitis B Immunoglobulin Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Human Hepatitis B Immunoglobulin Price by Application (2017-2028) & (USD/MT)
Figure 40. North America Human Hepatitis B Immunoglobulin Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 41. North America Human Hepatitis B Immunoglobulin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Human Hepatitis B Immunoglobulin Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 45. Europe Human Hepatitis B Immunoglobulin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Human Hepatitis B Immunoglobulin Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 52. Asia-Pacific Human Hepatitis B Immunoglobulin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. China Taiwan Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Latin America Human Hepatitis B Immunoglobulin Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 63. Latin America Human Hepatitis B Immunoglobulin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 64. Mexico Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Brazil Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Argentina Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Middle East & Africa Human Hepatitis B Immunoglobulin Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 68. Middle East & Africa Human Hepatitis B Immunoglobulin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Turkey Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Saudi Arabia Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. UAE Human Hepatitis B Immunoglobulin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Human Hepatitis B Immunoglobulin Value Chain
Figure 73. Human Hepatitis B Immunoglobulin Production Process
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed